Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-997-4 | CAS number: 18096-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral (OECD 401), rat: LD50 > 2000 mg/kg bw (limit test)
Dermal (OECD 402), rat: LD50 > 2000 mg/kg bw (limit test)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Feb - 06 Mar 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (1981)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 weeks
- Weight at study initiation: males: 120 - 139 g; females: 122 - 138 g
- Housing: animals were housed in groups of five by sex in solid-floor polypropylene cages with sawdust bedding
- Diet: Rat and Mouse Expanded Diet No. 1, Special Diet Services Limited, Witham, Essex, U.K., ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23
- Humidity (%): 39 - 55
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
- Doses:
- Preliminary study: 25, 200, 2000 and 5000 mg/kg bw
Main study: 2000 mg/kg bw - No. of animals per sex per dose:
- Preliminary study: 1
Main study: 5 - Control animals:
- no
- Details on study design:
- Preliminary study:
- Duration of observation period following administration: 5 days
- Frequency of observations: Animals were observed 1 and 4 hours after dosing and then daily for 5 days.
- Necropsy of survivors performed: no
Main study:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for deaths and evidence of overt toxicity 1 and 4 hours after dosing and subsequently once daily for 14 days. Individual bodyweights were recorded on the day of treatment (day 0) and on days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Preliminary study:
- The female rat dosed with 5000 mg/kg bw died on day 1. All other animals survived until the end of the study. From this mortality data the oral LD50 was considered to be approximately 5000 mg/kg bw and a dose level of 2000 mg/kg bw was selected for the main study.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities were observed until the end of the study.
- Clinical signs:
- other: Common signs of toxicity noted on the first day were hunched posture, lethargy, piloerection, decreased respiratory rate and ataxia.
- Gross pathology:
- No abnormalities were noted at necropsy of animals killed at the end of the study.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- In this acute oral toxicity study in rats a LD50 value of > 2000 mg/kg bw was found.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- no analytical data, insufficient documentation, only summary available, only 2 animals tested
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (1981)
- Deviations:
- yes
- Remarks:
- no analytical data, insufficient documentation, only summary available, only 2 animals tested
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw
- Doses:
- 250, 500, 1000, 2000 and 4000 mg/kg bw
- No. of animals per sex per dose:
- 2
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- The LD50 was determined graphically.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 850 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: graphic determination
- Mortality:
- 2/2 animals died in the high dose group (4000 mg/kg bw) 45 min to 4 h after test substance application. No mortalities were detected in the other dose groups.
- Clinical signs:
- other: Sedation, ataxia, dyspnea, ptosis, muscular hypotonia, tremor, side-and supine position were detected at and above 500 mg/kg bw.
- Gross pathology:
- Pale liver parenchyma and gritty kidney surface were detected.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- In this acute oral toxicity study in rats a LD50 value of 2850 mg/kg bw was found.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 2), and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Additional information
Oral
The acute oral toxicity of the test substance was assessed in a study according to OECD Guideline 401 and in compliance with GLP (1990). Based on a preliminary study a total dose of 2000 mg/kg bw (limit test) was administered to 5 male and 5 female rats. Animals were observed for mortality and general clinical conditions 1 and 4 h after administration and once daily thereafter for 14 days. Body weights were recorded on the day of administration and on days 7 and 14. Macroscopic examination was performed in the end of the observation period at terminal sacrifice. None of the animals died. Common signs of toxicity noted during the day of dosing were hunched posture, lethargy, piloerection and decreased respiratory rate. An isolated incident of ataxia was also noted 1 h after dosing. The body weight gain was not affected by the administration of the test substance. No abnormalities were observed at necropsy. Based on the results of this study, the oral LD50 value was determined to be > 2000 mg/kg bw in rats.
In a supporting study, the acute oral toxicity of the test substance was assessed equivalent to OECD Guideline 401 in mice (1979). Doses of 250, 500, 1000, 2000 and 4000 mg/kg bw test substance were administered to 2 male mice each. Two animals died at 4000 mg/kg bw 45 min to 4 h after dosing after they were found in a comatose state. No mortalities occurred in the other dose groups. Clinical signs observed at and above 500 mg/kg bw were sedation, ataxia, dyspnea, ptosis, muscular hypotonia, tremor, side-and supine position. In necropsy pale liver parenchyma and gritty kidney surface were detected. Based on the results of this study, the graphically determined oral LD50 value was 2850 mg/kg bw in mice.
Dermal
The acute dermal toxicity of the test substance was assessed in a limit test performed in 5 male and 5 female Wistar rats according to OECD Guideline 402 and in compliance with GLP (1999). The test substance was applied at a single dose of 2000 mg/kg bw to the clipped skin of the animals and was then held in contact with a semi-occlusive dressing for 24 hours. Animals were observed for mortality, overt signs of toxicity and evidence of primary irritation for a 14-day period. Body weights were recorded prior to administration and on days 7 and 14 thereafter. Macroscopic examination was performed at the end of the observation period at terminal sacrifice. None of the animals died and no signs of systemic toxicity or signs of skin irritation were observed. The body weight gain was not affected by the administration of the test substance. No abnormalities were observed at necropsy. Based on the results of this study, the LD50 value for acute dermal toxicity was determined to be > 2000 mg/kg bw in rats.
Justification for classification or non-classification
The available data on acute oral and dermal toxicity of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
